デフォルト表紙
市場調査レポート
商品コード
1515371

AAV受託開発・製造機関市場:ワークフロー別、培養タイプ別、治療領域別、方法別、用途別、エンドユーザー別、地域別- 産業分析、市場規模、市場シェア、2024年~2032年予測

AAV Contract Development and Manufacturing Organizations Market, By Workflow, By Culture Type, By Therapeutic Area, By Method, By Application, By End User, By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 356 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
AAV受託開発・製造機関市場:ワークフロー別、培養タイプ別、治療領域別、方法別、用途別、エンドユーザー別、地域別- 産業分析、市場規模、市場シェア、2024年~2032年予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 356 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

AAV受託開発・製造組織の市場規模は2023年に6億7,756万米ドルとなり、2024年から2032年にかけてCAGR 16.9%で拡大

AAV受託開発・製造機関市場-市場力学

遺伝子治療試験の増加により、AAVベクターの必要性が高まっています。

ウイルスベクター受託開発・製造機関(CDMO)の世界市場は、遺伝子治療の進歩や政府および大手市場関係者による投資の増加により、今後数年間で大きく成長する見通しです。この成長は主に、遺伝子治療の研究開発におけるアデノ随伴ウイルス(AAV)ベクターの需要の高まりに後押しされており、AAV CDMOがその生産と製造において果たす極めて重要な役割が浮き彫りになっています。

革新的な技術や製造施設に対する政府の投資はさらに市場拡大に寄与しています。自動化、クラウドコンピューティング、産業用ロボット、人工知能、モノのインターネットなどの新技術は、製造プロセスをより効率的にしています。アデノ随伴ウイルス(AAV)CDMOは、バイオ医薬品業界をサポートするために不可欠な専門知識とインフラを提供し、増大する需要を満たすAAVベクターの効率的な生産を保証しています。このような要因から、AAV CDMOs市場は、遺伝子治療の採用増加やバイオ医薬品製造の進歩に牽引され、予測期間を通じて力強い成長を遂げるものと思われます。

AAV開発製造受託機関市場-主な洞察

弊社リサーチアナリストの分析によると、世界市場は予測期間(2024-2032年)に約16.9%のCAGRで毎年成長すると予測されています。

ワークフローのセグメンテーションに基づくと、ダウンストリーム処理が2023年に最大市場シェアを示すと予測されました。

培養タイプ別では、接着培養が2023年に主要なタイプでした。

治療領域別では、神経疾患が2023年の主要タイプでした。

方法別では、in vivoが2023年の主要タイプでした。

用途別では、細胞・遺伝子治療が2023年の主要タイプでした。

エンドユーザー別では、製薬会社が2023年の主要タイプでした。

地域別では、北米が2023年の主要収益源でした。

AAV受託開発・製造機関市場-セグメンテーション分析:

世界のAAV受託開発・製造機関市場は、ワークフロー、培養タイプ、治療領域、方法、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場はワークフローに基づいて2つのカテゴリーに分けられる:上流工程」と「下流工程」です。ダウンストリーム処理とは、AAVベクターが細胞培養で生産された後、単離や精製に関わる精製、濃縮、製剤化のステップを指します。これには、細胞溶解、清澄化、クロマトグラフィー(アフィニティークロマトグラフィー、イオン交換クロマトグラフィーなど)、ろ過、製剤化などの工程が含まれます。AAVベクター分野における下流処理の優位性は、臨床使用に適した高純度・高力価のベクター製剤を得るために、AAVベクターを精製・濃縮することが極めて重要であることに起因しています。下流処理は、AAVベクターが汚染物質や不純物を含まず、安定性を維持し、安全性、有効性、保存安定性を高める方法で製剤化されることを保証します。

市場は培養タイプによって4つのカテゴリーに分けられる:接着培養と懸濁培養接着培養は、処理された表面に接着して単層を形成する細胞を培養します。この方法は動物細胞の研究に理想的であるが、自然形態とは異なり、平坦な2次元環境に限定されます。様々な用途に有用であるが、接着培養は表面積に依存するため、スケーラビリティの点で限界があります。

AAV受託開発・製造機関市場-地理的洞察

AAV遺伝子治療分野は、いくつかの重要な要因によって北米で大きな成長を遂げています。第一に、この地域には遺伝子治療技術の進歩に特化した研究センターや研究機関が数多く存在します。これらの研究機関は、最先端の研究開発を実施し、AAVベクター技術と治療応用におけるイノベーションを促進する上で極めて重要な役割を果たしています。こうした研究機関の努力の積み重ねが、広範な遺伝性疾患、神経変性疾患、がんをターゲットとする新規治療法の強力なパイプラインに貢献しています。

さらに、北米の連邦政府機関は、地域の細胞・遺伝子治療研究インフラを強化するために多額の投資を割り当てています。

AAV受託開発・製造機関市場-競合情勢:

市場の主要プレーヤーは、Thermo Fischer Scientific, Inc.、Oxford Biomedica、Charles River Laboratories International, Inc.、Creative Biogene、GenScript ProBio、Merck KGaA、Catalent Inc.、FUJIFILM Diosynth Biotechnologies、Lonza、Curia Global, Inc.、Takara Bio Inc.です。これらの企業は、AAVベクター製造市場の前進と拡大に重要な役割を果たしています。これらの企業の努力の積み重ねが、遺伝子治療の発展と治療に革命をもたらす可能性への重要な貢献となっています。

目次

第1章 AAV受託開発・製造機関市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 AAV受託開発・製造機関の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 AAV受託開発・製造機関業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 AAV受託開発・製造機関市場: COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 AAV受託開発・製造機関の市場情勢

  • AAV受託開発・製造機関の市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 AAV受託開発・製造機関市場- ワークフロー別

  • 概要
    • ワークフロー別セグメントシェア分析
    • 上流処理
    • 下流処理

第8章 AAV受託開発・製造機関市場- 培養タイプ別

  • 概要
    • 文化タイプ別セグメントシェア分析
    • 接着培養
    • 懸濁培養製剤

第9章 AAV受託開発・製造組織市場- 治療領域別

  • 概要
    • 治療領域別セグメントシェア分析
    • 神経学的障害
    • 代謝障害
    • 眼疾患
    • 筋・神経筋疾患
    • 感染症
    • 出血性疾患
    • 炎症と線維症
    • その他の治療領域

第10章 AAV受託開発・製造機関市場- 方法別

  • 概要
    • セグメントシェア分析(方法別)
    • 試験管内
    • 生体内

第11章 AAV受託開発・製造機関市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 細胞・遺伝子治療
    • 開発、ワクチン開発
    • バイオ医薬品・製薬
    • 発見、生物医学研究

第12章 AAV受託開発・製造機関市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 製薬および製薬会社
    • 学術研究機関その他

第13章 AAV受託開発・製造機関市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インダ
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第14章 主要ベンダー分析-AAV受託開発・製造機関業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • Catalent Inc.
    • Charles River Laboratories International, Inc.
    • Danaher(Aldevron)
    • Merck KGaA
    • Biovian Oy
    • Esco Lifesciences(Esco Aster Pte. Ltd.)
    • GenScript ProBio
    • Takara Bio, Inc.
    • Oxford Biomedica
    • Belief Biomed, Inc.
    • Forge Biologics

第15章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE AAV Contract Development and Manufacturing Organizations Market: Workflow Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Workflow
  • TABLE Global AAV Contract Development and Manufacturing Organizations Market, by Workflow 2019-2032 (USD Million)
  • TABLE AAV Contract Development and Manufacturing Organizations Market: Culture Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Culture Type
  • TABLE Global AAV Contract Development and Manufacturing Organizations Market, by Culture Type 2019-2032 (USD Million)
  • TABLE AAV Contract Development and Manufacturing Organizations Market: Therapeutic Area Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global AAV Contract Development and Manufacturing Organizations Market, by Therapeutic Area 2019-2032 (USD Million)
  • TABLE AAV Contract Development and Manufacturing Organizations Market: Method Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Method
  • TABLE Global AAV Contract Development and Manufacturing Organizations Market, by Method 2019-2032 (USD Million)
  • TABLE AAV Contract Development and Manufacturing Organizations Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global AAV Contract Development and Manufacturing Organizations Market, by Application 2019-2032 (USD Million)
  • TABLE AAV Contract Development and Manufacturing Organizations Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global AAV Contract Development and Manufacturing Organizations Market, by End User 2019-2032 (USD Million)
  • TABLE AAV Contract Development and Manufacturing Organizations Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global AAV Contract Development and Manufacturing Organizations Market, by Region 2019-2032 (USD Million)
  • TABLE North America AAV Contract Development and Manufacturing Organizations Market, by Country, 2019-2032 (USD Million)
  • TABLE North America AAV Contract Development and Manufacturing Organizations Market, by Workflow, 2019-2032 (USD Million)
  • TABLE North America AAV Contract Development and Manufacturing Organizations Market, by Culture Type, 2019-2032 (USD Million)
  • TABLE North America AAV Contract Development and Manufacturing Organizations Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE North America AAV Contract Development and Manufacturing Organizations Market, by End User, 2019-2032 (USD Million)
  • TABLE North America AAV Contract Development and Manufacturing Organizations Market, by Method, 2019-2032 (USD Million)
  • TABLE North America AAV Contract Development and Manufacturing Organizations Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe AAV Contract Development and Manufacturing Organizations Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe AAV Contract Development and Manufacturing Organizations Market, by Workflow, 2019-2032 (USD Million)
  • TABLE Europe AAV Contract Development and Manufacturing Organizations Market, by Culture Type, 2019-2032 (USD Million)
  • TABLE Europe AAV Contract Development and Manufacturing Organizations Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Europe AAV Contract Development and Manufacturing Organizations Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe AAV Contract Development and Manufacturing Organizations Market, by Method, 2019-2032 (USD Million)
  • TABLE Europe AAV Contract Development and Manufacturing Organizations Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific AAV Contract Development and Manufacturing Organizations Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific AAV Contract Development and Manufacturing Organizations Market, by Workflow, 2019-2032 (USD Million)
  • TABLE Asia Pacific AAV Contract Development and Manufacturing Organizations Market, by Culture Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific AAV Contract Development and Manufacturing Organizations Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Asia Pacific AAV Contract Development and Manufacturing Organizations Market, by End User, 2019-2032 (USD Million)
  • TABLE Acia Pacific AAV Contract Development and Manufacturing Organizations Market, by Method, 2019-2032 (USD Million)
  • TABLE Acia Pacific AAV Contract Development and Manufacturing Organizations Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America AAV Contract Development and Manufacturing Organizations Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America AAV Contract Development and Manufacturing Organizations Market, by Workflow, 2019-2032 (USD Million)
  • TABLE Latin America AAV Contract Development and Manufacturing Organizations Market, by Culture Type, 2019-2032 (USD Million)
  • TABLE Latin America AAV Contract Development and Manufacturing Organizations Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Latin America AAV Contract Development and Manufacturing Organizations Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America AAV Contract Development and Manufacturing Organizations Market, by Method, 2019-2032 (USD Million)
  • TABLE Latin America AAV Contract Development and Manufacturing Organizations Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa AAV Contract Development and Manufacturing Organizations Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa AAV Contract Development and Manufacturing Organizations Market, by Workflow, 2019-2032 (USD Million)
  • TABLE Middle East and Africa AAV Contract Development and Manufacturing Organizations Market, by Culture Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa AAV Contract Development and Manufacturing Organizations Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Middle East and Africa AAV Contract Development and Manufacturing Organizations Market, by Method, 2019-2032 (USD Million)
  • TABLE Middle East and Africa AAV Contract Development and Manufacturing Organizations Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa AAV Contract Development and Manufacturing Organizations Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE AAV Contract Development and Manufacturing Organizations Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Workflow segment market share analysis, 2023 & 2032
  • FIGURE Workflow segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Culture Type segment market share analysis, 2023 & 2032
  • FIGURE Culture Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Therapeutic Area segment market share analysis, 2023 & 2032
  • FIGURE Therapeutic Area segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Method segment market share analysis, 2023 & 2032
  • FIGURE Method segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America AAV Contract Development and Manufacturing Organizations Market share and leading players, 2023
  • FIGURE Europe AAV Contract Development and Manufacturing Organizations Market share and leading players, 2023
  • FIGURE Asia Pacific AAV Contract Development and Manufacturing Organizations Market share and leading players, 2023
  • FIGURE Latin America AAV Contract Development and Manufacturing Organizations Market share and leading players, 2023
  • FIGURE Middle East and Africa AAV Contract Development and Manufacturing Organizations Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe AAV Contract Development and Manufacturing Organizations Market share analysis by country, 2023
  • FIGURE Germany AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific AAV Contract Development and Manufacturing Organizations Market share analysis by country, 2023
  • FIGURE India AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America AAV Contract Development and Manufacturing Organizations Market share analysis by country, 2023
  • FIGURE Brazil AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa AAV Contract Development and Manufacturing Organizations Market share analysis by country, 2023
  • FIGURE Saudi Arabia AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA AAV Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3263

REPORT HIGHLIGHT

AAV Contract Development and Manufacturing Organizations Market size was valued at USD 677.56 Million in 2023, expanding at a CAGR of 16.9% from 2024 to 2032.

Adeno-associated viruses (AAVs) are small, non-pathogenic viruses famous for their utility as vectors in gene therapy and biomedical research. They are characterized by their ability to infect cells and deliver genetic material without causing disease in humans. AAV vectors are increasingly being used in the clinic to treat a wide range of diseases and tissues such as Parkinson's disease and Peripheral nerve regeneration.

AAV Contract Development and Manufacturing Organizations Market- Market Dynamics

Increasing gene therapy trials elevate AAV vector requirements.

The global market for viral vector Contract Development and Manufacturing Organizations (CDMOs) is poised for significant growth in the coming years, driven by advancements in gene therapy and increasing investments by governments and leading market players. This growth is primarily fueled by rising demand for adeno-associated virus (AAV) vectors in gene therapy R&D, highlighting the pivotal role played by AAV CDMOs in their production and manufacturing.

Government investments in innovative technologies and manufacturing facilities further contribute to market expansion. Novel technologies such as automation, cloud computing, industrial robotics, artificial intelligence, and the Internet of Things are making manufacturing processes more efficient. Adeno-associated virus (AAV) CDMOs provide specialized expertise and infrastructure crucial for supporting the biopharmaceutical industry, ensuring efficient production of AAV vectors to meet the growing demand. With these factors in play, the AAV CDMOs market is set to witness robust growth throughout the forecast period, driven by the increasing adoption of gene therapy and advancements in biopharmaceutical manufacturing.

AAV Contract Development and Manufacturing Organizations Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.9% over the forecast period (2024-2032)

Based on Workflow segmentation, Downstream Processing was predicted to show maximum market share in the year 2023

Based on Culture Type segmentation, Adherent Culture was the leading type in 2023

Based on Therapeutic Area segmentation, Neurological disorders were the leading type in 2023

Based on the Method, in vivo was the leading type in 2023

Based on Application, Cell & Gene Therapy was the leading type in 2023

Based on End User segmentation, Pharmaceutical Companies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

AAV Contract Development and Manufacturing Organizations Market- Segmentation Analysis:

The Global AAV Contract Development and Manufacturing Organizations Market is segmented based on Workflow, Culture Type, Therapeutic Area, Method, Application, End User, and Region.

The market is divided into two categories based on Workflow: Upstream Processing and Downstream Processing. Downstream processing refers to the purification, concentration, and formulation steps involved in isolating and refining AAV vectors after they have been produced in cell culture. This includes processes such as cell lysis, clarification, chromatography (e.g., affinity chromatography, ion exchange chromatography), filtration, and formulation. The dominance of downstream processing in the AAV vector sector is due to the critical need to purify and concentrate AAV vectors to achieve high-purity and high-titer vector preparations suitable for clinical use. Downstream processing ensures that AAV vectors are free from contaminants and impurities, maintain stability, and are formulated in a manner that enhances their safety, efficacy, and storage stability.

The market is divided into four categories based on Culture Type: Adherent culture and Suspension Adherent cultures involve growing cells that attach to a treated surface, forming a single layer. This method is ideal for studying animal cells but limits them to a flat, 2D environment, unlike their natural form. While useful for various applications, adherent cultures can be limited in terms of scalability due to their surface area dependence.

AAV Contract Development and Manufacturing Organizations Market- Geographical Insights

The AAV gene therapy sector is experiencing significant growth in North America, driven by several key factors. Firstly, the region hosts a substantial number of research centers and institutes dedicated to advancing gene therapy technologies. These institutions play a pivotal role in conducting cutting-edge research and development and fostering innovation in AAV vector technologies and therapeutic applications. Their collective efforts contribute to the robust pipeline of novel therapies targeting a wide range of genetic disorders, neurodegenerative diseases, and cancers.

Additionally, federal agencies in North America have allocated substantial investments to bolster the local cell and gene therapy research infrastructure.

AAV Contract Development and Manufacturing Organizations Market- Competitive Landscape:

Major players in the market are Thermo Fischer Scientific, Inc., Oxford Biomedica, Charles River Laboratories International, Inc., Creative Biogene, GenScript ProBio, Merck KGaA, Catalent Inc., FUJIFILM Diosynth Biotechnologies, Lonza, Curia Global, Inc., and Takara Bio Inc. These companies, among many others, play a crucial role in advancing and expanding the AAV vector manufacturing market. Their collective efforts underscore their critical contribution to the development of gene therapy and its potential to revolutionize medical treatments.

Recent Developments:

In May 2024, Andelyn Biosciences was selected to manufacture AAV therapies under CIRM, aimed to advance BGTC's mission to develop platforms and standards and propel the development and delivery of customized gene therapies for millions affected with rare diseases.

In Feb 2024, Charles River Laboratories International, Inc. introduced reference materials for its adeno-associated virus (AAV) and lentiviral vector (LVV) portfolio, aimed at enhancing the efficiency of Cell and Gene Therapy (CGT) research and development as it transitions to Good Manufacturing Practice (GMP) standards.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific, Inc.

Catalent Inc.

Charles River Laboratories International, Inc.

Danaher (Aldevron)

Merck KGaA

Biovian Oy

Esco Lifesciences (Esco Aster Pte. Ltd.)

GenScript ProBio

Takara Bio, Inc.

Oxford Biomedica

Belief Biomed, Inc.

Forge Biologics

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY WORKFLOW- MARKET ANALYSIS, 2019 - 2032

  • Upstream Processing
  • Downstream Processing

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY CULTURE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Adherent Culture
  • Suspension Culture

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Neurological disorders
  • Metabolic disorders
  • Ophthalmic disorders
  • Muscular/Neuromuscular disorders
  • Infectious diseases
  • Bleeding disorders
  • Inflammation and fibrosis
  • Other therapeutic areas

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY METHOD- MARKET ANALYSIS, 2019 - 2032

  • In vitro
  • In vivo

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cell & Gene Therapy
  • Development, Vaccine Development
  • Biopharmaceutical & Pharmaceutical
  • Discovery, Biomedical Research

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biopharmaceutical Companies
  • Academic & Research Institutes

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AAV Contract Development and Manufacturing Organizations Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AAV Contract Development and Manufacturing Organizations Market Snippet by Workflow
    • 2.1.2. AAV Contract Development and Manufacturing Organizations Market Snippet by Culture Type
    • 2.1.3. AAV Contract Development and Manufacturing Organizations Market Snippet by Therapeutic Area
    • 2.1.4. AAV Contract Development and Manufacturing Organizations Market Snippet by Method
    • 2.1.5. AAV Contract Development and Manufacturing Organizations Market Snippet by Application
    • 2.1.6. AAV Contract Development and Manufacturing Organizations Market Snippet by End User
    • 2.1.7. AAV Contract Development and Manufacturing Organizations Market Snippet by Country
    • 2.1.8. AAV Contract Development and Manufacturing Organizations Market Snippet by Region
  • 2.2. Competitive Insights

3. AAV Contract Development and Manufacturing Organizations Key Market Trends

  • 3.1. AAV Contract Development and Manufacturing Organizations Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AAV Contract Development and Manufacturing Organizations Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AAV Contract Development and Manufacturing Organizations Market Opportunities
  • 3.4. AAV Contract Development and Manufacturing Organizations Market Future Trends

4. AAV Contract Development and Manufacturing Organizations Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AAV Contract Development and Manufacturing Organizations Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AAV Contract Development and Manufacturing Organizations Market Landscape

  • 6.1. AAV Contract Development and Manufacturing Organizations Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AAV Contract Development and Manufacturing Organizations Market - By Workflow

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Workflow, 2023 & 2032 (%)
    • 7.1.2. Upstream Processing
    • 7.1.3. Downstream Processing

8. AAV Contract Development and Manufacturing Organizations Market - By Culture Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Culture Type, 2023 & 2032 (%)
    • 8.1.2. Adherent Culture
    • 8.1.3. Suspension Culture Formulation

9. AAV Contract Development and Manufacturing Organizations Market - By Therapeutic Area

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
    • 9.1.2. Neurological disorders
    • 9.1.3. Metabolic disorders
    • 9.1.4. Ophthalmic disorders
    • 9.1.5. Muscular/Neuromuscular disorders
    • 9.1.6. Infectious diseases
    • 9.1.7. Bleeding disorders
    • 9.1.8. Inflammation and fibrosis
    • 9.1.9. Other therapeutic areas

10. AAV Contract Development and Manufacturing Organizations Market - By Method

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Method, 2023 & 2032 (%)
    • 10.1.2. In vitro
    • 10.1.3. In vivo

11. AAV Contract Development and Manufacturing Organizations Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 11.1.2. Cell & Gene Therapy
    • 11.1.3. Development, Vaccine Development
    • 11.1.4. Biopharmaceutical & Pharmaceutical
    • 11.1.5. Discovery, Biomedical Research

12. AAV Contract Development and Manufacturing Organizations Market - By End User

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 12.1.2. Pharmaceutical & Pharmaceutical Companies
    • 12.1.3. Academic & Research Institutes Others

13. AAV Contract Development and Manufacturing Organizations Market- By Geography

  • 13.1. Introduction
    • 13.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 13.2. North America
    • 13.2.1. Overview
    • 13.2.2. AAV Contract Development and Manufacturing Organizations Key Manufacturers in North America
    • 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.2.4. North America Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.2.5. North America Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.2.6. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.2.7. North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.2.9. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.2.10. U.S.
      • 13.2.10.1. Overview
      • 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.10.3. U.S. Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.2.10.4. U.S. Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.2.10.5. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.2.10.6. U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.2.10.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.2.10.8. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.2.11. Canada
      • 13.2.11.1. Overview
      • 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.11.3. Canada Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.2.11.4. Canada Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.2.11.5. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.2.11.6. Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.2.11.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.2.11.8. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3. Europe
    • 13.3.1. Overview
    • 13.3.2. AAV Contract Development and Manufacturing Organizations Key Manufacturers in Europe
    • 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.3.4. Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.3.5. Europe Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.3.7. Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.9. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.10. Germany
      • 13.3.10.1. Overview
      • 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.10.3. Germany Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.3.10.4. Germany Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.3.10.5. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.3.10.6. Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.3.10.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.10.8. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.11. Italy
      • 13.3.11.1. Overview
      • 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.11.3. Italy Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.3.11.4. Italy Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.3.11.5. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.3.11.6. Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.3.11.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.11.8. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.12. United Kingdom
      • 13.3.12.1. Overview
      • 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.12.3. United Kingdom Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.3.12.4. United Kingdom Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.3.12.5. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.3.12.6. United Kingdom Market Size and Method, By End User, 2019 - 2032 (US$ Million)
      • 13.3.12.7. United Kingdom Market Size and Application, By End User, 2019 - 2032 (US$ Million)
      • 13.3.12.8. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.13. France
      • 13.3.13.1. Overview
      • 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.13.3. France Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.3.13.4. France Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.3.13.5. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.3.13.6. France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.3.13.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.13.8. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 13.3.13.9.
    • 13.3.14. Russia
      • 13.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.14.2. Russia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.3.14.3. Russia Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.3.14.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.3.14.5. Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.3.14.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.14.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.15. Netherlands
      • 13.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.15.2. Netherlands Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.3.15.3. Netherlands Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.3.15.4. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.3.15.5. Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.3.15.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.15.7. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.16. Sweden
      • 13.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.16.2. Sweden Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.3.16.3. Sweden Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.3.16.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.3.16.5. Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.3.16.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.16.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.17. Poland
      • 13.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.17.2. Poland Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.3.17.3. Poland Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.3.17.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.3.17.5. Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.18. Rest of Europe
      • 13.3.18.1. Overview
      • 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.18.3. Rest of the Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.3.18.4. Rest of the Europe Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.3.18.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.3.18.6. Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.3.18.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.18.8. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4. Asia Pacific (APAC)
    • 13.4.1. Overview
    • 13.4.2. AAV Contract Development and Manufacturing Organizations Key Manufacturers in Asia Pacific
    • 13.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.4.4. Asia Pacific Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.4.5. Asia Pacific Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.4.7. Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.9. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.10. Inda
      • 13.4.10.1. Overview
      • 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.10.3. India Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.4.10.4. India Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.4.10.5. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.4.10.6. India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.4.10.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.10.8. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.11. China
      • 13.4.11.1. Overview
      • 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.11.3. China Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.4.11.4. China Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.4.11.5. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.4.11.6. China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.4.11.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.11.8. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.12. Japan
      • 13.4.12.1. Overview
      • 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.12.3. Japan Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.4.12.4. Japan Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.4.12.5. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.4.12.6. Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million
      • 13.4.12.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million
      • 13.4.12.8. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.13. South Korea
      • 13.4.13.1. Overview
      • 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.13.3. South Korea Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.4.13.4. South Korea Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.4.13.5. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.4.13.6. South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.4.13.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.13.8. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.14. Australia
      • 13.4.14.1. Overview
      • 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.14.3. Australia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.4.14.4. Australia Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.4.14.5. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.4.14.6. Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.4.14.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.14.8. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.15. Thailand
      • 13.4.15.1. Overview
      • 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.15.3. Thailand Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.4.15.4. Thailand Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.4.15.5. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.4.15.6. Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.4.15.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.15.8. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.16. Indonesia
      • 13.4.16.1. Overview
      • 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.16.3. Indonesia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.4.16.4. Indonesia Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.4.16.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.4.16.6. Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.4.16.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.16.8. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.17. Philippines
      • 13.4.17.1. Overview
      • 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.17.3. Philippines Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.4.17.4. Philippines Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.4.17.5. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.4.17.6. Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.4.17.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.17.8. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.18. Rest of APAC
      • 13.4.18.1. Overview
      • 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.18.3. Rest of APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.4.18.4. Rest of APAC Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.4.18.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.4.18.6. Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.4.18.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.18.8. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.5. Latin America
    • 13.5.1. Overview
    • 13.5.2. AAV Contract Development and Manufacturing Organizations Key Manufacturers in Latin America
    • 13.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.5.4. Latin America Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.5.5. Latin America Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.5.6. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.5.7. Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.5.9. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.10. Brazil
      • 13.5.10.1. Overview
      • 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.10.3. Brazil Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.5.10.4. Brazil Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.5.10.5. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.5.10.6. Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.5.10.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.10.8. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.11. Mexico
      • 13.5.11.1. Overview
      • 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.11.3. Mexico Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.5.11.4. Mexico Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.5.11.5. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.5.11.6. Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.5.11.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.11.8. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.12. Argentina
      • 13.5.12.1. Overview
      • 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.12.3. Argentina Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.5.12.4. Argentina Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.5.12.5. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.5.12.6. Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.5.12.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.12.8. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.13. Colombia
      • 13.5.13.1. Overview
      • 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.13.3. Colombia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.5.13.4. Colombia Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.5.13.5. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.5.13.6. Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.5.13.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.13.8. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.14. Rest of LATAM
      • 13.5.14.1. Overview
      • 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.14.3. Rest of LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.5.14.4. Rest of LATAM Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.5.14.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.5.14.6. Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.5.14.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.14.8. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6. Middle East and Africa
    • 13.6.1. Overview
    • 13.6.2. AAV Contract Development and Manufacturing Organizations Key Manufacturers in Middle East and Africa
    • 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.6.4. Middle East and Africa Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.6.5. Middle East and Africa Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.6.7. Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.10. Saudi Arabia
      • 13.6.10.1. Overview
      • 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.10.3. Saudi Arabia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.6.10.4. Saudi Arabia Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.6.10.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.6.10.6. Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.6.10.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.10.8. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.11. United Arab Emirates
      • 13.6.11.1. Overview
      • 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.11.3. United Arab Emirates Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.6.11.4. United Arab Emirates Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.6.11.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.6.11.6. United Arab Emirates Market Size and Method, By End User, 2019 - 2032 (US$ Million)
      • 13.6.11.7. United Arab Emirates Market Size and Application, By End User, 2019 - 2032 (US$ Million)
      • 13.6.11.8. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.12. Israel
      • 13.6.12.1. Overview
      • 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.12.3. Israel Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.6.12.4. Israel Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.6.12.5. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.6.12.6. Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.6.12.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.12.8. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.13. Turkey
      • 13.6.13.1. Overview
      • 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.13.3. Turkey Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.6.13.4. Turkey Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.6.13.5. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.6.13.6. Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.6.13.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.13.8. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.14. Algeria
      • 13.6.14.1. Overview
      • 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.14.3. Algeria Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.6.14.4. Algeria Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.6.14.5. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.6.14.6. Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.6.14.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.14.8. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.15. Egypt
      • 13.6.15.1. Overview
      • 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.15.3. Egypt Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.6.15.4. Egypt Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.6.15.5. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.6.15.6. Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.6.15.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.15.8. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.16. Rest of MEA
      • 13.6.16.1. Overview
      • 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.16.3. Rest of MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 13.6.16.4. Rest of MEA Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
      • 13.6.16.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 13.6.16.6. Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 13.6.16.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.16.8. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

14. Key Vendor Analysis- AAV Contract Development and Manufacturing Organizations Industry

  • 14.1. Competitive Dashboard
  • 14.2. Company Profiles
    • 14.2.1. Thermo Fisher Scientific, Inc.
    • 14.2.2. Catalent Inc.
    • 14.2.3. Charles River Laboratories International, Inc.
    • 14.2.4. Danaher (Aldevron)
    • 14.2.5. Merck KGaA
    • 14.2.6. Biovian Oy
    • 14.2.7. Esco Lifesciences (Esco Aster Pte. Ltd.)
    • 14.2.8. GenScript ProBio
    • 14.2.9. Takara Bio, Inc.
    • 14.2.10. Oxford Biomedica
    • 14.2.11. Belief Biomed, Inc.
    • 14.2.12. Forge Biologics

15. 360 Degree Analyst View

16. Appendix

  • 16.1. Research Methodology
  • 16.2. References
  • 16.3. Abbreviations
  • 16.4. Disclaimer
  • 16.5. Contact Us